| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $18.15M | $12.92M | $15.38M | $13.23M | $9.54M |
| SG&A | $9.42M | $6.93M | $7.52M | $6.01M | $3.35M |
| Operating Income | -$27.57M | -$19.85M | -$22.90M | -$19.23M | -$12.89M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$26.44M | -$19.00M | -$22.26M | -$19.09M | -$12.89M |
| EPS (basic) | -1.3200 | -1.1100 | -1.4300 | -1.5100 | -3.0200 |
| EPS (diluted) | -1.3200 | -1.1100 | -1.4300 | -1.5100 | -3.0200 |
| Shares (diluted) | $21.81M | $17.11M | $15.56M | $12.66M | $4.27M |